Navigation Links
Fish Oil Supplements Won't Help in Multiple Sclerosis: Study
Date:4/16/2012

By Steven Reinberg
HealthDay Reporter

MONDAY, April 16 (HealthDay News) -- Omega-3 fatty acid supplements don't appear to have any benefit on multiple sclerosis (MS), according a study by Norwegian researchers.

Multiple sclerosis affects about 2.5 million people worldwide. Some prior research has indicated that omega-3 fatty acid supplements might have anti-inflammatory effects that could benefit those with the disease, according to background information in the study.

Omega-3 fatty acids are found in cold-water fish, such as salmon, and in fish oil supplements.

"Our study provides evidence that omega-3 supplementation has no beneficial effect on MS, neither given alone nor in combination with interferon treatment," said lead researcher Dr. Oivind Torkildsen, from Haukeland University Hospital, in Bergen. Interferon is a standard drug given to MS patients.

"Our data do not suggest that omega-3 fatty acid supplementation was harmful or that it interfered with interferon beta treatment," he added.

This study is important, not only for neurologists and MS patients, but also for general practitioners, who frequently advise patients about lifestyle interventions and complementary approaches to MS treatment, Torkildsen said.

The report was published in the April 16 online edition of the Archives of Neurology.

For the study, Torkildsen's team looked at 92 MS patients, aged 18 to 55, with a form of the disease known as relapsing-remitting multiple sclerosis.

Half of the patients were given the supplement alone or the supplement plus injections of interferon beta-1a. The other half received an inactive placebo.

After six months, all patients were given interferon beta-1a three times a week for an additional 18 months.

When the patients underwent MRI brain scans to look for new lesions, the researchers found no effect on the disease among those taking omega-3 fatty acid supplements.

The results were the same whether omega-3 fatty acid supplements were used alone or in combination with interferon beta-1a, the study authors noted.

These findings were in contrast with two other studies that showed possible positive effects from fish oil supplements, Torkildsen and colleagues pointed out.

No difference existed between the groups in the number of relapses during the first six months of treatment or after 24 months, and there were no differences in fatigue or quality of life, according to the results.

Commenting on the study, Dr. Kottil Rammohan, a professor of neurology and director of the MS division at the University of Miami Miller School of Medicine, said, "It doesn't surprise me that omega-3 fatty acids had no effect on MS. I have never looked upon omega-3 fatty acids as having an effect on MS and I have a lot of patients who take these supplements for heart health," he said.

However, Rammohan added, "This study won't change my advice to patients to take omega-3 fatty acid supplements because they have other health benefits."

More information

For more information on MS, visit the National Multiple Sclerosis Society.

SOURCES: Oivind Torkildsen, M.D., Ph.D., Haukeland University Hospital, Bergen, Norway; Kottil Rammohan, M.D., professor of neurology and director, MS division, University of Miami Miller School of Medicine; April 16, 2012, Archives of Neurology, online


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Omega-3 Supplements No Help Against Repeat Heart Trouble: Review
2. Vitamin E Supplements Dont Affect Heart Failure Risk: Study
3. Vitamin A Supplements Might Cut Melanoma Risk: Study
4. Selenium Supplements May Help -- or Harm
5. Soy isoflavone supplements did not provide breast cancer protections
6. Eating smart: Researcher studies foods, dietary supplements that may reduce risk of prostate cancer
7. Researchers identify phthalates in numeruous medicines and supplements
8. Women advised to avoid ZEN bust-enhancing supplements because of possible cancer risk
9. Buyer, Beware of Over-the-Counter Thyroid Supplements: Study
10. Folic acid supplements in early pregnancy may reduce the risk of severe language delay in children
11. Ginger Supplements Might Ease Inflammation Linked to Colon Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Fish Oil Supplements Won't Help in Multiple Sclerosis: Study
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... are unfamiliar with. The article goes on to state that individuals are now more ... these less common operations such as calf and cheek reduction. The Los Angeles area ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle ... chronic pain and the benefits of holistic treatments, Serenity Recovery Center of ... Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the red ...
(Date:6/24/2016)... ... 2016 , ... The Pulmonary Hypertension Association (PHA) learned during ... two significant new grants to support its work to advance research and patient ... recognizing patients, medical professionals and scientists for their work in fighting pulmonary hypertension ...
(Date:6/24/2016)... San Francisco, CA (PRWEB) , ... June 24, ... ... at CitiDent, is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has ... , self-ligating Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, ... minimum wage raise to $12 an hour by 2020 and then adjusting it yearly to ... value of the minimum wage, assure the wage floor does not erode again, and make ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 23, 2016 Any dentist who has made an ... current process. Many of them do not even offer this ... and high laboratory costs involved. And those who ARE able ... such a high cost that the majority of today,s patients ... Parsa Zadeh , founder of Dental Evolutions Inc. and ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
(Date:6/23/2016)... and BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment of ... Farma Brasil as the company,s second affiliate in Latin America . ... ... Manager of Astellas Farma Colombia ... ...
Breaking Medicine Technology: